| Name | Title | Contact Details |
|---|
CoLucid was founded in 2005 by Pappas Ventures to advance innovative drug candidates with the potential to provide safe and effective treatments for CNS disorders. The company`s investors include Pappas Ventures, Domain Associates, Care Capital, Novo Ventures, Triathalon Medical Ventures, TVM Life Science Management, Auriga Partners and Pearl Street Venture Funds. The company is developing oral lasmiditan for the treatment of migraine headache and intravenous lasmiditan for treatment of headache pain by health care professionals.
Prospect Biosystems is a Newark, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Community Pharmacies, Lp is a Augusta, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Lyne Laboratories is a Brockton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.